Envoy Medical, Inc. (COCHW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 30K 60K 90K Q3 '24: 56K Q4 '24: 42K Q1 '25: 46K Q2 '25: 78K Q3 '25: 42K Q4 '25: 75K Q1 '26: 39K Q2 '26: 51K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-300K -200K -100K 0 100K 200K 300K Q3 '24: -131K Q4 '24: -115K Q1 '25: -180K Q2 '25: -156K Q3 '25: -161K Q4 '25: -136K Q1 '26: -274K Q2 '26: -227K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '24: -5M Q4 '24: -4.5M Q1 '25: -5.1M Q2 '25: -5.1M Q3 '25: -5.7M Q4 '25: -6.4M Q1 '26: -6M Q2 '26: -5.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '24: -6M Q4 '24: -4.6M Q1 '25: -5M Q2 '25: -5.7M Q3 '25: -6.5M Q4 '25: -6.6M Q1 '26: -4.4M Q2 '26: -6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q3 '24: 187K Q4 '24: 157K Q1 '25: 226K Q2 '25: 234K Q3 '25: 203K Q4 '25: 211K Q1 '26: 313K Q2 '26: 278K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '24: -2.6M Q4 '24: -5.1M Q1 '25: -3.7M Q2 '25: -4.5M Q3 '25: -4.3M Q4 '25: -5.7M Q1 '26: -6.1M Q2 '26: -5.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '23: 1M Q4 '23: -11.2M Q1 '24: -5.7M Q3 '24: -3.8M Q1 '25: -3.7M Q2 '25: -4.5M Q3 '25: -4.3M Q4 '25: -5.9M Q3 '23 Q4 '23 Q1 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '24: 18.6M Q2 '24: 18.6M Q3 '24: 18.6M Q1 '25: 21.3M Q2 '25: 21.4M Q3 '25: 21.9M Q1 '26: 68.9M Q2 '26: 104M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '24: -1.17 Q4 '24: -1.49 Q1 '25: -1.37 Q2 '25: -1.40 Q3 '25: -1.36 Q4 '25: -1.22 Q1 '26: -1.01 Q2 '26: -0.76 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.